Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cardiac Rhythm Management Firms Targeted By DoJ Fraud Investigation

This article was originally published in The Gray Sheet

Executive Summary

Subpoenas served to Guidant, Medtronic and St. Jude Medical by the U.S. Department of Justice appear to be investigating potential improper inducements to increase sales of pacemakers and ICDs

You may also be interested in...

News In Brief

St. Jude Medical inks DOJ settlement

News In Brief

St. Jude Medical inks DOJ settlement

DOJ Joins Whistleblower Suit Alleging St. Jude Used Phony Trials To Pay MDs

The Department of Justice is joining a qui tam action against St. Jude alleging the firm used four post-marketing studies to funnel kickbacks to physicians, according to documents filed in a Boston federal court Aug. 5

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts